ArticleInternational journal of clinical oncology2026

Efficacy and safety of second-line fluorouracil, leucovorin, and irinotecan plus ramucirumab according to prior first-line regimens in metastatic colorectal cancer: a multicenter retrospective study.

Toshinori Yanagawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.